SEC Company Response from Cellectis S.A. (CLLS) (CIK 0001627281) (CLLS) — Mar 23, 2015
Cellectis S.A. (CLLS) (CIK 0001627281)
Date: March 23, 2015 · CIK: 0001627281 · Accession: 0001193125-15-101792
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-202205
Letter
Correspondence
Cellectis S.A.
8, rue de la Croix Jarry
Paris, France
March 23, 2015
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jeffrey P. Riedler
Mr. Johnny Gharib
Mr. Bryan Pitko
RE: Cellectis S.A.
Registration Statement on Form F-1 (File No. 333-202205)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on March 24, 2015 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes Boris Dolgonos, an attorney with our legal counsel, Jones Day, to orally modify or withdraw this request for acceleration. The Registrant also hereby requests a copy of the written order verifying the effective date.
In connection with this request, the Registrant acknowledges that:
•
should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please contact Boris Dolgonos of Jones Day at (212) 326-3430 if you have any questions concerning the foregoing. Thank you for your attention to this matter.
Very truly yours,
CELLECTIS S.A.
Show Raw Text
CORRESP 1 filename1.htm Correspondence Cellectis S.A. 8, rue de la Croix Jarry 75013 Paris, France March 23, 2015 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Jeffrey P. Riedler Mr. Johnny Gharib Mr. Bryan Pitko RE: Cellectis S.A. Registration Statement on Form F-1 (File No. 333-202205) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, Cellectis S.A. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on March 24, 2015 at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable. The Registrant hereby authorizes Boris Dolgonos, an attorney with our legal counsel, Jones Day, to orally modify or withdraw this request for acceleration. The Registrant also hereby requests a copy of the written order verifying the effective date. In connection with this request, the Registrant acknowledges that: • should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the Registrant may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please contact Boris Dolgonos of Jones Day at (212) 326-3430 if you have any questions concerning the foregoing. Thank you for your attention to this matter. Very truly yours, CELLECTIS S.A. By: /s/ André Choulika André Choulika Chief Executive Officer cc: Boris Dolgonos, Jones Day